Biotech

All Articles

J &amp J drops phase 2 dengue applicant in most recent switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable health condition pipe has claimed anot...

Relay drops 10% of staff after earlier layoffs in July

.Accuracy medication biotech Relay Therapies is actually losing about 10% of its own workforce in in...

Pentixapharm scores $22M IPO to advance radiopharma trials

.Pentixapharm has generated practically twenty thousand europeans ($ 22 million) coming from an IPO,...

Lundbeck faucets Charles Waterway for AI-enabled neuro medication discovery

.Lundbeck has utilized Charles Stream Laboratories' artificial intelligence functionalities to help ...

Big pharma, biotech 'won't essentially be actually cooperative' in artificial intelligence: S&ampP

.Significant Pharma is actually committing intensely in artificial intelligence to slash progression...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Bio has trapped $115 million in set B funds to advance preclinical antibody courses develop...

IGM turns coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences finished last year laying off personnel as well as simplifying its cancer pipeline....

Shattuck axes CD47 program over weak efficacy records, gives up 40% of workers and also drops Ono handle

.Shattuck Labs has actually pounded one more nail in to the coffin of CD47. After observing a "modes...

BioMarin goes CAMPing, striking RNA deal with biotech

.BioMarin is actually adding kindling to the R&ampD fire, assaulting a fit with CAMP4 Therapies for ...

Cash- strapped Gritstone begins seek tactical choices as cancer cells vaccine data underwhelm

.Gritstone biography has actually introduced financiers to explore "possible value-maximizing tactic...